Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Duane Mellor, Lead for Evidence-Based Medicine and Nutrition, Aston Medical School, Aston University

Mounjaro: type 2 diabetes drug more effective than Ozempic to launch in the UK — here’s what you need to know

Mounjaro helps control blood sugar levels. Mohammed_Al_Ali/ Shutterstock

A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.

Mounjaro is an injectable treatment that helps the body to both control blood glucose (sugars) after meals and regulate appetite. Research into the drug has shown it’s more effective in controlling blood sugar and leads to greater weight loss compared with the type 2 diabetes drugs currently available for prescription.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.